JP2023535485A5 - - Google Patents

Info

Publication number
JP2023535485A5
JP2023535485A5 JP2023505903A JP2023505903A JP2023535485A5 JP 2023535485 A5 JP2023535485 A5 JP 2023535485A5 JP 2023505903 A JP2023505903 A JP 2023505903A JP 2023505903 A JP2023505903 A JP 2023505903A JP 2023535485 A5 JP2023535485 A5 JP 2023535485A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
sequence described
cdr3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023505903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535485A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2021/051046 external-priority patent/WO2022020945A1/en
Publication of JP2023535485A publication Critical patent/JP2023535485A/ja
Publication of JP2023535485A5 publication Critical patent/JP2023535485A5/ja
Pending legal-status Critical Current

Links

JP2023505903A 2020-07-29 2021-07-27 抗cd22シングルドメイン抗体および治療用コンストラクト Pending JP2023535485A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063058203P 2020-07-29 2020-07-29
US63/058,203 2020-07-29
PCT/CA2021/051046 WO2022020945A1 (en) 2020-07-29 2021-07-27 Anti-cd22 single domain antibodies and therapeutic constructs

Publications (2)

Publication Number Publication Date
JP2023535485A JP2023535485A (ja) 2023-08-17
JP2023535485A5 true JP2023535485A5 (https=) 2024-08-05

Family

ID=80038079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023505903A Pending JP2023535485A (ja) 2020-07-29 2021-07-27 抗cd22シングルドメイン抗体および治療用コンストラクト

Country Status (10)

Country Link
US (1) US20230265185A1 (https=)
EP (1) EP4188952A4 (https=)
JP (1) JP2023535485A (https=)
KR (1) KR20230042090A (https=)
CN (1) CN116234559A (https=)
AU (1) AU2021317073A1 (https=)
BR (1) BR112023001452A2 (https=)
CA (1) CA3187472A1 (https=)
IL (1) IL300116A (https=)
WO (1) WO2022020945A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230340461A1 (en) * 2022-02-14 2023-10-26 Twist Bioscience Corporation Combinatorial dna assembly for multispecific antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105384825B (zh) * 2015-08-11 2018-06-01 南京传奇生物科技有限公司 一种基于单域抗体的双特异性嵌合抗原受体及其应用
AU2018388997B2 (en) * 2017-12-20 2025-04-03 Lentigen Technology, Inc. Compositions and methods for treating HIV/AIDS with immunotherapy
WO2020053634A1 (en) * 2018-09-16 2020-03-19 Habibi Anbouhi Mahdi Anti-cd22 heavy-chain variable domain antibody
CN111217908B (zh) * 2019-11-29 2021-07-06 深圳普瑞金生物药业有限公司 Cd22单域抗体、核苷酸序列、试剂盒、car-t病毒载体及car-t细胞

Similar Documents

Publication Publication Date Title
JP2021177771A5 (https=)
TWI883026B (zh) 抗dll3嵌合抗原受體及其用途
JP2024023228A5 (https=)
JP2023518134A5 (https=)
EP3472205B1 (en) Chimeric antigen receptor
JP2017527275A5 (https=)
JP2022542543A5 (https=)
JP2021512635A5 (https=)
JP2021526844A5 (https=)
JP2019537433A5 (https=)
JP2025142045A5 (https=)
JP2024532485A5 (https=)
JP2019525771A5 (https=)
JP2022542559A5 (https=)
JP2017522893A5 (https=)
JP2023507729A5 (https=)
JP2022009816A5 (https=)
KR20230143177A (ko) 신규한 항-cd24 항체
JP2024532482A5 (https=)
JP2024510739A5 (https=)
JP2024504162A5 (https=)
JP2022548112A5 (https=)
JP2022521956A5 (https=)
JP2024515919A5 (https=)
JP2023515055A5 (https=)